Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shandong Weigao Group Medical Polymer Co Ltd Reaffirms FY 2013 Revenue Guidance-Conference Call


Thursday, 30 May 2013 08:00am EDT 

Shandong Weigao Group Medical Polymer Co Ltd announced that the Company has previously given the guidance for fiscal 2013, the sales increase, compared to fiscal 2012 would be 20%. For the first quarter the increase is 17.5%. So the Company remain on the guidance of 20% for fiscal 2013. The Company reported revenue of CNY3.689 billion in fiscal 2012. 

Company Quote